These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34561774)

  • 1. Barriers and Facilitators to Behavior Change for Individuals with Severe Mental Illness who Received the Transdiagnostic Intervention for Sleep and Circadian Dysfunction in a Community Mental Health Setting.
    Armstrong CC; Aguilera A; Hwang J; Harvey AG
    J Behav Health Serv Res; 2022 Apr; 49(2):204-220. PubMed ID: 34561774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C) for serious mental illness in community mental health part 3: study protocol to evaluate sustainment in a hybrid type 2 effectiveness-implementation cluster-randomized trial.
    Sarfan LD; Agnew ER; Diaz M; Cogan A; Spencer JM; Esteva Hache R; Wiltsey Stirman S; Lewis CC; Kilbourne AM; Harvey AG
    Trials; 2024 Jan; 25(1):54. PubMed ID: 38225677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C) for serious mental illness in community mental health part 2: study protocol for a hybrid type 2 effectiveness-implementation cluster-randomized trial using train-the-trainer.
    Callaway CA; Sarfan LD; Agnew ER; Dong L; Spencer JM; Hache RE; Diaz M; Howlett SA; Fisher KR; Yates HEH; Stice E; Kilbourne AM; Buysse DJ; Harvey AG
    Trials; 2023 Aug; 24(1):503. PubMed ID: 37550730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C) for serious mental illness in community mental health part 1: study protocol for a hybrid type 2 effectiveness-implementation cluster-randomized trial.
    Sarfan LD; Agnew ER; Diaz M; Dong L; Fisher K; Spencer JM; Howlett SA; Hache RE; Callaway CA; Kilbourne AM; Buysse DJ; Harvey AG
    Trials; 2023 Mar; 24(1):198. PubMed ID: 36927461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C) for serious mental illness in community mental health part 2: Study protocol for a hybrid type 2 effectiveness-implementation cluster- randomized trial using train-the-trainer.
    Callaway CA; Sarfan LD; Agnew ER; Dong L; Spencer JM; Hache RE; Diaz M; Howlett SA; Fisher KR; Yates HEH; Stice E; Kilbourne AM; Buysse DJ; Harvey AG
    Res Sq; 2023 Jun; ():. PubMed ID: 37398014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C) for serious mental illness in community mental health part 3: Study protocol to evaluate sustainment in a hybrid type 2 effectiveness-implementation cluster-randomized trial.
    Sarfan LD; Agnew ER; Diaz M; Cogan A; Spencer JM; Hache RE; Stirman SW; Lewis CC; Kilbourne AM; Harvey A
    Res Sq; 2023 Oct; ():. PubMed ID: 37961426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementing a transdiagnostic sleep and circadian intervention in a community mental health setting: A qualitative process evaluation with community stakeholders.
    Gumport NB; Yu SH; Harvey AG
    Psychiatry Res; 2020 Nov; 293():113443. PubMed ID: 32890862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial of the Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C) to improve serious mental illness outcomes in a community setting.
    Harvey AG; Dong L; Hein K; Yu SH; Martinez AJ; Gumport NB; Smith FL; Chapman A; Lisman M; Mirzadegan IA; Mullin AC; Fine E; Dolsen EA; Gasperetti CE; Bukosky J; Alvarado-Martinez CG; Kilbourne AM; Rabe-Hesketh S; Buysse DJ
    J Consult Clin Psychol; 2021 Jun; 89(6):537-550. PubMed ID: 34264701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A transdiagnostic sleep and circadian treatment to improve severe mental illness outcomes in a community setting: study protocol for a randomized controlled trial.
    Harvey AG; Hein K; Dong L; Smith FL; Lisman M; Yu S; Rabe-Hesketh S; Buysse DJ
    Trials; 2016 Dec; 17(1):606. PubMed ID: 27998295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers and facilitators to the implementation of a school-based physical activity policy in Canada: application of the theoretical domains framework.
    Weatherson KA; McKay R; Gainforth HL; Jung ME
    BMC Public Health; 2017 Oct; 17(1):835. PubMed ID: 29061140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers and facilitators to social prescribing in child and youth mental health: perspectives from the frontline.
    Hayes D; Olsson A; Begum S; Bertotti M; Jarvis-Beesley P; Stapley E
    Eur Child Adolesc Psychiatry; 2024 May; 33(5):1465-1479. PubMed ID: 37405485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes From the Transdiagnostic Sleep and Circadian Intervention (TranS-C) for Midlife and Older Adults With Serious Mental Illness and Sleep and Circadian Dysfunction.
    Sarfan LD; Gasperetti CE; Gumport NB; Harvey AG
    Behav Ther; 2022 Jul; 53(4):585-599. PubMed ID: 35697424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mediators and moderators of outcome from the Transdiagnostic Sleep and Circadian Intervention for adults with severe mental illness in a community setting.
    Armstrong CC; Dong L; Harvey AG
    Behav Res Ther; 2022 Apr; 151():104053. PubMed ID: 35152036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers and facilitators to shared decision making in child and youth mental health: clinician perspectives using the Theoretical Domains Framework.
    Hayes D; Edbrooke-Childs J; Town R; Wolpert M; Midgley N
    Eur Child Adolesc Psychiatry; 2019 May; 28(5):655-666. PubMed ID: 30229306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Validation of a Provider-Reported Fidelity Measure for the Transdiagnostic Sleep and Circadian Intervention in a Community Mental Health Setting.
    Gumport NB; Yu SH; Mullin AC; Mirzadegan IA; Harvey AG
    Behav Ther; 2020 Sep; 51(5):800-813. PubMed ID: 32800307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of module dosage on treatment response in a modular transdiagnostic intervention for sleep and circadian dysfunction (TranS-C).
    Callaway CA; Sarfan LD; Gumport NB; Harvey AG
    Behav Res Ther; 2023 Sep; 168():104368. PubMed ID: 37478529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating sleep and circadian problems to promote mental health: perspectives on comorbidity, implementation science and behavior change.
    Harvey AG
    Sleep; 2022 Apr; 45(4):. PubMed ID: 35079830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of the Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C) in a community setting: Unpacking comorbidity.
    Sarfan LD; Hilmoe HE; Gumport NB; Gasperetti CE; Zieve GG; Harvey AG
    Behav Res Ther; 2021 Oct; 145():103948. PubMed ID: 34428642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memory and learning for sleep and circadian treatment in serious mental illness treated in a community mental health setting.
    Gumport NB; Harvey AG
    Behav Res Ther; 2022 Feb; 149():104029. PubMed ID: 34995953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.